VLUE iShares MSCI USA Value Factor ETF

Expense Ratio
0.15%
Dividend
1.96%
Previous close
$145.22
Est. 12 months change
+12.36%
Projected Price
$163.16

Profitability Metrics

Return on Equity (ROE)
18.33%
Return on Assets (ROA)
7.21%
Return on Invested Capital (ROIC)
16.40%
Weighted Average Cost of Capital (WACC)
7.87%
ROIC - WACC
8.53%
Updated : 2026-04-03 17:48 ET

Valuation Metrics

P/E Ratio
16.71
Forward P/E
10.47
PEG Ratio
1.65
Debt Current Ratio
1.82

Growth & Cash Flow

Gross Margin
45.03%
Operating Margin
21.96%
FCF Margin
15.87%
TTM Revenue Growth
25.30%
Projected 12M EPS Growth
59.49%

Price Change

Price % from 50 SMA
-1.54%
Price % from 200 SMA
11.00%
6 Months
14.40%
1 Year
35.42%
2 Years
35.99%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MU9.48%
CSCO5.53%
INTC5.01%
AMAT3.70%
GM3.54%
T3.31%
VZ3.28%
MRK2.02%
BAC1.95%
C1.92%

ETF Analysis

Fund Overview

iShares MSCI USA Value Factor ETF (VLUE) currently reports 147 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is MU (9.48%), CSCO (5.53%), INTC (5.01%), with MU as the largest single weight at 9.48%. Together, the top three holdings account for 20.02%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Profitability & Capital Efficiency

Examining the portfolio through a capital allocation lens, ROIC is 16.40%, WACC is 7.87%, and the economic spread is 8.53%. On balance, holdings are generating returns above their cost of capital, though the margin is slim enough to warrant attention. Supporting metrics show ROE at 18.33% and ROA at 7.21%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 16.71, forward P/E of 10.47, PEG of 1.65. A moderate trailing-to-forward spread implies earnings growth is anticipated, though the scale of expected improvement is not dramatic. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. The aggregate current ratio of 1.82 reflects a holding set with workable near-term liquidity positions. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

From gross to free cash flow, gross margin sits at 45.03%, operating margin at 21.96%, and free cash flow margin at 15.87%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.

Growth & Forward Outlook

Revenue momentum and analyst targets together paint a picture where the estimated 12-month price change of 12.48%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 25.30% reflecting top-line acceleration that, if sustained, supports the forward earnings case. Reported revenue growth is the operational foundation; the analyst target spread shows what the market is willing to pay above it — and that premium can evaporate quickly if delivery slips. For investors, the central question is whether the operating momentum visible in revenues is durable enough to support the price appreciation implied by consensus targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The fundamental case holds up across most key dimensions — the combination of positive economic spread, reasonable valuation, and analyst support is constructive.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.